Skip to main content
. 2011 Apr 1;44(3):907–919. doi: 10.1007/s11255-011-9947-4

Table 2.

Selected haematological parameters used for characteristics of the studied groups

Parameter mHD P value
mHD1 vs. mHD2
HV as controls
mHD1 mHD2
RBC (1012/l) 3.25 ± 0.47*** 3.11 ± 0.42*** 0.03 4.6 ± 0.8
HCT (%) 33.3 ± 318*** 32.31 ± 3.9*** 0.64 44.3 ± 7.2
HGB (g/dl) 10.62 ± 1.54*** 10.5 ± 1.21*** 0.76 14.9 ± 2.0
MCH (pg) 32.86 ± 4.79 34.16 ± 3.7 0.15 34.2 ± 3.7
MCV (fL) 98.68 ± 5.86*** 98.91 ± 5.72*** 0.81 104.6 ± 11.1
TIBC (μmol/l) 37.66 ± 5.27*** 42.4.8 ± 8.47*** 0.0001 59.6 ± 5.3
UIBC (μmol/l) 21.92 ± 8.04*** 17.942 ± 8.2*** 0.0021 36.4 ± 3.1
Fe (μmol/l) 15.73 ± 6.68*** 15.06 ± 7.86*** 0.63 22.7 ± 9.1
sFn (ng/ml) 1749.55 ± 179.98*** 1804.72 ± 1086.53*** 0.88 188.2 ± 10.6
TSAT (%) 42.6 ± 18.95*** 37.84.8 ± 24.7*** 0.21 38.4 ± 6.5

Subjects were divided into patients treated with maintenance haemodialysis (mHD1—at the beginning of the study, mHD2—after 1 year of the study) and healthy volunteers (HV) as controls

The differences between mHD1 and mHD2 were estimated by paired t test. To compare mHD1 and mHD2 with HV as controls, unpaired the Student’s t test for normally distributed variables and the Mann–Whitney rank sum test for the variables with non-normal distribution were used

Data were given are means ± SD

mHD1 patients treated with maintenance haemodialysis at the beginning of the study, mHD2 patients treated with maintenance haemodialysis after 1 year of the study, RBC red blood cells, HCT haematocrit, HGB haemoglobin, MCH mean haemoglobin concentration, MCV mean corpuscular volume, TIBC total iron-binding capacity, UIBC unsaturated iron-binding capacity, Fe serum iron, sFn serum ferritin, TSAT transferrin saturation

Significant differences when P < 0.05

*** P < 0.001 versus HV